BusinessPROVECTUS BIOPHARMACEUTICALS PROVIDES UPDATE ON GI CANCER PROGRAM FOR INVESTIGATIONAL DRUG PV-10By Nasdaq OMXFeb 22, 2018, 12:01 PM UTC
BusinessCascadian Therapeutics Announces FDA Orphan Drug Designation Granted to Tucatinib for the Treatment of HER2+ Metastatic Colorectal CancerBy Nasdaq OMXSep 27, 2017, 11:00 AM UTC
